ProMIS Neurosciences, Inc. (PMN)
9.86
+0.15
(+1.54%)
USD |
NASDAQ |
Jun 09, 16:00
9.51
-0.35
(-3.55%)
After-Hours: 16:07
ProMIS Neurosciences EPS Diluted (Quarterly) : -1.263 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Edesa Biotech, Inc. | -0.4939 |
| Arrowhead Pharmaceuticals, Inc. | -0.932 |
| Oncolytics Biotech, Inc. | -0.0823 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | 2.878 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.244M |
| Total Expenses (Quarterly) | 8.244M |
| Enterprise Value | 23.23M |
| Earnings Yield | -196.8% |
| Normalized Earnings Yield | -196.85 |